Comparison of 1-month and 1-year outcomes between abciximab and control group in patients with primary PCI.

<p>Efficacy of abciximab compared with control for (A1): 1-month mortality and (B1): 1-year mortality; (A2): 1-month reinfarction and (B2): 1-year reinfarction; (A3): 1-month TLR and (B3): 1-year TLR; (A4): 1-month MACEs and (B4):1-year MACEs in diabetic patients with primary PCI.</p>